These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 34898617)

  • 41. Defer vaccination of people who have had covid-19.
    Bhopal R
    BMJ; 2021 Feb; 372():n465. PubMed ID: 33619168
    [No Abstract]   [Full Text] [Related]  

  • 42. Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis.
    Hogan AB; Winskill P; Watson OJ; Walker PGT; Whittaker C; Baguelin M; Brazeau NF; Charles GD; Gaythorpe KAM; Hamlet A; Knock E; Laydon DJ; Lees JA; Løchen A; Verity R; Whittles LK; Muhib F; Hauck K; Ferguson NM; Ghani AC
    Vaccine; 2021 May; 39(22):2995-3006. PubMed ID: 33933313
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Global, regional, and national estimates of target population sizes for covid-19 vaccination: descriptive study.
    Wang W; Wu Q; Yang J; Dong K; Chen X; Bai X; Chen X; Chen Z; Viboud C; Ajelli M; Yu H
    BMJ; 2020 Dec; 371():m4704. PubMed ID: 33323388
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Public Perspectives on COVID-19 Vaccine Prioritization.
    Persad G; Emanuel EJ; Sangenito S; Glickman A; Phillips S; Largent EA
    JAMA Netw Open; 2021 Apr; 4(4):e217943. PubMed ID: 33835172
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Allergic reactions to COVID-19 vaccines].
    Geersing TH; Tempels-Pavlica Ž; Borgsteede SD
    Ned Tijdschr Geneeskd; 2021 Feb; 165():. PubMed ID: 33651507
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vaccines and variants: Modelling insights into emerging issues in COVID-19 epidemiology.
    Caldwell JM; Le X; McIntosh L; Meehan MT; Ogunlade S; Ragonnet R; O'Neill GK; Trauer JM; McBryde ES
    Paediatr Respir Rev; 2021 Sep; 39():32-39. PubMed ID: 34417121
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is there a role for childhood vaccination against COVID-19?
    Eberhardt CS; Siegrist CA
    Pediatr Allergy Immunol; 2021 Jan; 32(1):9-16. PubMed ID: 33113210
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Priority allocation of pandemic influenza vaccines in Australia - Recommendations of 3 community juries.
    Degeling C; Williams J; Carter SM; Moss R; Massey P; Gilbert GL; Shih P; Braunack-Mayer A; Crooks K; Brown D; McVernon J
    Vaccine; 2021 Jan; 39(2):255-262. PubMed ID: 33317870
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Public Health COVID-19 Vaccination Strategy to Maximize the Health Gains for Every Single Vaccine Dose.
    Barnabas RV; Wald A
    Ann Intern Med; 2021 Apr; 174(4):552-553. PubMed ID: 33395339
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prioritizing COVID-19 vaccination efforts and dose allocation within Madagascar.
    Rasambainarivo F; Ramiadantsoa T; Raherinandrasana A; Randrianarisoa S; Rice BL; Evans MV; Roche B; Randriatsarafara FM; Wesolowski A; Metcalf JC
    BMC Public Health; 2022 Apr; 22(1):724. PubMed ID: 35413894
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The long road ahead for COVID-19 vaccination in Africa.
    Jerving S
    Lancet; 2021 Sep; 398(10303):827-828. PubMed ID: 34481563
    [No Abstract]   [Full Text] [Related]  

  • 53. Unfolding the Determinants of COVID-19 Vaccine Acceptance in China.
    Yin F; Wu Z; Xia X; Ji M; Wang Y; Hu Z
    J Med Internet Res; 2021 Jan; 23(1):e26089. PubMed ID: 33400682
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The vaccines are here: Are we ready?].
    Ruiz F; Fernández-Niño J
    Biomedica; 2021 Mar; 41(1):5-7. PubMed ID: 33761184
    [No Abstract]   [Full Text] [Related]  

  • 55. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.
    Lustig Y; Sapir E; Regev-Yochay G; Cohen C; Fluss R; Olmer L; Indenbaum V; Mandelboim M; Doolman R; Amit S; Mendelson E; Ziv A; Huppert A; Rubin C; Freedman L; Kreiss Y
    Lancet Respir Med; 2021 Sep; 9(9):999-1009. PubMed ID: 34224675
    [TBL] [Abstract][Full Text] [Related]  

  • 56. COVID-19 vaccine prioritization of incarcerated people relative to other vulnerable groups: An analysis of state plans.
    Strodel R; Dayton L; Garrison-Desany HM; Eber G; Beyrer C; Arscott J; Rubenstein L; Sufrin C
    PLoS One; 2021; 16(6):e0253208. PubMed ID: 34129620
    [TBL] [Abstract][Full Text] [Related]  

  • 57. COVID-19 epidemic in New York City: development of an age group-specific mathematical model to predict the outcome of various vaccination strategies.
    Li M; Zu J; Zhang Y; Ma L; Shen M; Li Z; Ji F
    Virol J; 2022 Mar; 19(1):43. PubMed ID: 35292054
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Venezuela is collapsing without COVID-19 vaccines.
    Loyo ESL; González MJ; Esparza J
    Lancet; 2021 May; 397(10287):1806. PubMed ID: 33992140
    [No Abstract]   [Full Text] [Related]  

  • 59. A Reserve System for the Equitable Allocation of a Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine.
    Makhoul AT; Drolet BC
    Chest; 2021 Mar; 159(3):1292-1293. PubMed ID: 33453180
    [No Abstract]   [Full Text] [Related]  

  • 60. Clinical outcomes and cost-effectiveness of COVID-19 vaccination in South Africa.
    Reddy KP; Fitzmaurice KP; Scott JA; Harling G; Lessells RJ; Panella C; Shebl FM; Freedberg KA; Siedner MJ
    Nat Commun; 2021 Oct; 12(1):6238. PubMed ID: 34716349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.